These include cancer genes that were not highlighted as such within that cancer type, such as ERBB3 (breast); SMC1A and POLR2A (bladder); BAP1 and SETD2 (cervical); MTOR (colorectal); USP9X and POLR2A (lung squamous cell carcinoma); MED12 and ZMYM3 (prostate); CDKN2A (melanoma); ERBB3 (stomach); and ERBB3 (endometrial). This evidence concerns the gene SETD2 and melanoma.